Back to Search
Start Over
Global Respiratory Syncytial Virus Prophylaxis Industry to 2030 - Featuring Abbvie, Sobi and Sanofi Among Others - ResearchAndMarkets.com
- Source :
- Business Wire. January 28, 2022
- Publication Year :
- 2022
-
Abstract
- DUBLIN -- The 'Respiratory Syncytial Virus Prophylaxis' GlobalData report has been added to ResearchAndMarkets.com's offering. Human respiratory syncytial virus (RSV) is an enveloped, single-stranded, negative-sense RNA orthopneumovirus belonging to the [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.690719889